Cargando…
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
BACKGROUND: Viral hepatitis deaths from acute infection, cirrhosis, and liver cancer have risen from the tenth to the seventh leading cause of death worldwide between 1990 and 2013. Even in the oral direct acting antiviral (DAA) agent era there are still large numbers of patients with unmet needs. M...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918728/ https://www.ncbi.nlm.nih.gov/pubmed/30288325 http://dx.doi.org/10.1186/s41124-017-0028-x |